Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $2.1 million.

  • Profound Medical's Gains from Investment Securities rose 555652.37% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 91390.52%. This contributed to the annual value of $2.3 million for FY2024, which is 5535.25% up from last year.
  • As of Q3 2025, Profound Medical's Gains from Investment Securities stood at $2.1 million, which was up 555652.37% from $2.1 million recorded in Q2 2025.
  • Over the past 5 years, Profound Medical's Gains from Investment Securities peaked at $2.3 million during Q4 2024, and registered a low of -$121000.0 during Q1 2023.
  • For the 3-year period, Profound Medical's Gains from Investment Securities averaged around $782577.7, with its median value being $160000.0 (2024).
  • In the last 5 years, Profound Medical's Gains from Investment Securities plummeted by 5467.42% in 2024 and then skyrocketed by 555652.37% in 2025.
  • Profound Medical's Gains from Investment Securities (Quarter) stood at $353000.0 in 2023, then surged by 549.05% to $2.3 million in 2024, then dropped by 6.18% to $2.1 million in 2025.
  • Its Gains from Investment Securities was $2.1 million in Q3 2025, compared to $2.1 million in Q2 2025 and $11000.0 in Q1 2025.